Elan Gorshein
DO, JD, MPH
Assistant Professor of Medicine (Hematology)
Research & Publications
Biography
News
Coauthors
Selected Publications
- “Double‐hit” ineffective erythropoiesis—concurrent β‐thalassemia with α‐gene triplication and myelodysplastic syndrome with SF3B1 mutationChen P, Gorshein E, Tormey C, Siddon A, Perincheri S. “Double‐hit” ineffective erythropoiesis—concurrent β‐thalassemia with α‐gene triplication and myelodysplastic syndrome with SF3B1 mutation. American Journal Of Hematology 2023, 98: 984-988. PMID: 36688500, DOI: 10.1002/ajh.26856.
- Enhanced Global Disease Assessment with Advanced Imaging and Targeted Myeloma Lesion Biopsy Highlights Spatial Heterogeneity and Detects Residual Disease in Multiple MyelomaBrowning S, Liu Y, Parker T, Bar N, Anderson T, Dhodapkar M, Seropian S, Halene S, Xu M, Syam R, Gorshein E, DiAdamo A, Talsania A, Kidwai W, Witt D, Chang V, Montanari F, Lischuk A, Wei W, Haims A, Neparidze N. Enhanced Global Disease Assessment with Advanced Imaging and Targeted Myeloma Lesion Biopsy Highlights Spatial Heterogeneity and Detects Residual Disease in Multiple Myeloma. Blood 2022, 140: 7308-7310. DOI: 10.1182/blood-2022-166325.
- Genomic Sequencing of Paired Bone Marrow and Focal Lesion Biopsies of Newly Diagnosed Multiple Myeloma Patients before and after Induction TherapyLiu Y, Browning S, VanOudenhove J, Biancon G, Bar N, Parker T, Anderson T, Dhodapkar M, Seropian S, Halene S, Xu M, Gorshein E, Talsania A, Kidwai W, Witt D, Chang V, Montanari F, Lischuk A, Haims A, Wei W, Neparidze N. Genomic Sequencing of Paired Bone Marrow and Focal Lesion Biopsies of Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy. Blood 2022, 140: 7086-7087. DOI: 10.1182/blood-2022-168109.
- Outcomes Among Primary Refractory Multiple Myeloma Patients in the Era of Monoclonal Antibodies: The Yale ExperienceLiu Y, Kywe B, Crawford L, Lora F, Bar N, Browning S, Gorshein E, Parker T, Neparidze N. Outcomes Among Primary Refractory Multiple Myeloma Patients in the Era of Monoclonal Antibodies: The Yale Experience. Blood 2021, 138: 1635. DOI: 10.1182/blood-2021-146619.
- Use of Denosumab after Zoledronic Acid in Patients with Multiple Myeloma: Real-World Experience from 2015 to 2019 at Yale Cancer CenterDosani T, Poteraj A, Parker T, Bar N, Browning S, Gorshein E, Anderson T, Insogna K, Neparidze N. Use of Denosumab after Zoledronic Acid in Patients with Multiple Myeloma: Real-World Experience from 2015 to 2019 at Yale Cancer Center. Blood 2021, 138: 4756. DOI: 10.1182/blood-2021-147466.
- Advanced Imaging and Targeted Myeloma Lesion Biopsies to Enhance Global Response Assessment and Evaluate Spatial Heterogeneity in Multiple MyelomaBrowning S, Parker T, Bar N, Anderson T, Dhodapkar M, Seropian S, Lee A, Prebet T, Halene S, Xu M, Gorshein E, Talsania A, Kidwai W, Witt D, Chang V, Lischuk A, Wei W, Haims A, Neparidze N. Advanced Imaging and Targeted Myeloma Lesion Biopsies to Enhance Global Response Assessment and Evaluate Spatial Heterogeneity in Multiple Myeloma. Blood 2020, 136: 20-22. DOI: 10.1182/blood-2020-136478.
- Impact of Insurance Status on Survival Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL): A Single Center ExperienceKrakora R, Shih W, Popli P, Gorshein E, Salaru G, David K, Bannerji R. Impact of Insurance Status on Survival Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL): A Single Center Experience. Blood 2019, 134: 5071. DOI: 10.1182/blood-2019-129390.
- Unusual Case of Esophageal Adenocarcinoma With Forearm Soft Tissue MetastasisJohn E, Gorshein E, Dayan M, Katz K, Malhotra U. Unusual Case of Esophageal Adenocarcinoma With Forearm Soft Tissue Metastasis. The American Journal Of Gastroenterology 2017, 112: s901. DOI: 10.14309/00000434-201710001-01664.
- Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental?Zelefsky M, Kollmeier M, Gorshein E, Pei X, Torres M, McBride S, Happersett L, Cohen G, Yamada Y. Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental? Radiotherapy And Oncology 2016, 121: 109-112. PMID: 27756494, PMCID: PMC5546832, DOI: 10.1016/j.radonc.2016.08.010.
- A Difficult Position: Appendicitis in Platelet Refractory, Severely Neutropenic PatientHa K, Gorshein E, John E, Gharibo M. A Difficult Position: Appendicitis in Platelet Refractory, Severely Neutropenic Patient. The American Journal Of Gastroenterology 2016, 111: s667. DOI: 10.14309/00000434-201610001-01462.
- The Case of Mistaken Identity: Entamoeba histolytica presenting as Community Acquired PneumoniaHa K, Gorshein E, Skole K. The Case of Mistaken Identity: Entamoeba histolytica presenting as Community Acquired Pneumonia. The American Journal Of Gastroenterology 2015, 110: s386. DOI: 10.14309/00000434-201510001-00894.
- Probiotic Enteric Regimen for Easing the Complications of TransplantGorshein E, Ambrosy S, Budney S, Vivas J, Manago J, McGrath M, Tyno A, Strair R. Probiotic Enteric Regimen for Easing the Complications of Transplant. Blood 2014, 124: 5877. DOI: 10.1182/blood.v124.21.5877.5877.
- Clinical Significance of HER2-Positive and Triple-Negative Status in Small (≤ 1 cm) Node-Negative Breast CancerGorshein E, Klein P, Boolbol S, Shao T. Clinical Significance of HER2-Positive and Triple-Negative Status in Small (≤ 1 cm) Node-Negative Breast Cancer. Clinical Breast Cancer 2014, 14: 309-314. PMID: 24703318, DOI: 10.1016/j.clbc.2014.02.007.
- Predictors of Post-Radiation Therapy Hip-Related Toxicity After Radiation Therapy for Prostate CancerZelefsky M, Gorshein E, Pei X, Schecter M, Kollmeier M. Predictors of Post-Radiation Therapy Hip-Related Toxicity After Radiation Therapy for Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s381. DOI: 10.1016/j.ijrobp.2013.06.1000.
- Predictors of Serum Testosterone Normalization after Neoadjuvant and Concurrent Androgen Deprivation Therapy in Conjunction with Radiotherapy for Localized Prostate CancerZelefsky M, Gorshein E, Pei X, Kollmeier M, Cox B, Yamada Y, Zhang Z. Predictors of Serum Testosterone Normalization after Neoadjuvant and Concurrent Androgen Deprivation Therapy in Conjunction with Radiotherapy for Localized Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s381. DOI: 10.1016/j.ijrobp.2011.06.606.